Clinical Study

Long-Term Antipsychotic Pediatric Safety Trial (Laps)

Posted Date: Nov 20, 2019

  • Investigator: Luis Patino Duran
  • Specialties: Adolescent Psychiatry/Psychology, Bipolar Disorder, Psychiatry/Psychology
  • Type of Study: Observational/Survey

This study is designed evaluate the weight changes associated with multi-year risperidone and aripiprazole therapy in children ages 3- <18 years. This study will also provide insights into the overall long-term safety and the quality of life effects of both drugs.


Use Of Either Risperidone Or Aripiprazole Mono-Antipsychotic Therapy As Prescribed By Participant’S Prescribing Medical Provider.


Schizophrenia, Bipolar Disorders, Irritability Associated With Autistic Disorder

For More Information:

Cathy Bailey
(513) 558-4731

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.